Muralidhara Padigaru

This inventor holds 7 USPTO granted patents. Top assignees: Curagen Corporation, Other. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muralidhara Padigaru. Retrieved from https://idiyas.com/inventor/muralidhara-padigaru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 62(Granted Patents)

Company Filing History:

6 out of 84

Curagen Corporation

patents

1 out of 834,513

Other

patents

Years Active: 2005-2007

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7253266 - Polypeptides of FGF-CX (2007-08-07),

2. 7122345 - Nucleic acid encoding a NOVX13 polypeptide (2006-10-17),

3. 7109000 - Proteins and nucleic acids encoding same (2006-09-19),

4. 7108972 - Proteins, polynucleotides encoding them and methods of using the same (2006-09-19),

5. 7034132 - Therapeutic polypeptides, nucleic acids encoding same, and methods of use (2006-04-25),

6. 6903201 - Proteins and nucleic acids encoding same (2005-06-07),

7. 6875570 - Proteins and nucleic acids encoding same (2005-04-05),

Title: Innovator Profile: Muralidhara Padigaru - Pioneering Medical Breakthroughs

Introduction: Muralidhara Padigaru, a talented inventor based in Branford, CT (US), has made a significant mark in the field of biotechnology with a remarkable portfolio of 7 patents. His groundbreaking work revolves around polypeptides and nucleic acids that have the potential to revolutionize detection and treatment methods for various pathological states.

Latest Patents: Padigaru's recent patents showcase his innovative spirit and commitment to advancing medical science. His inventions include the creation of FGF-CX, a novel polypeptide utilized in the detection and treatment of a wide range of health conditions. Additionally, his work on NOVX13 polypeptide encoding nucleic acid sequences offers promising prospects for diagnostic, therapeutic, and research applications in addressing human disorders.

Career Highlights: Throughout his career, Padigaru has been associated with esteemed companies such as Curagen Corporation, where his inventive prowess has flourished. His dedication to research and development has not only resulted in a substantial patent portfolio but has also positioned him as a key player in the biotech industry.

Collaborations: Padigaru's collaborative efforts with industry peers like Valerie Gerlach and Kimberly Spytek have further enriched his innovative endeavors. By teaming up with like-minded individuals, he has been able to drive forward-thinking projects and achieve groundbreaking milestones in the realm of biotechnology.

Conclusion: Muralidhara Padigaru's unwavering commitment to innovation and his penchant for pushing the boundaries of scientific discovery make him a standout figure in the world of biotechnology. His contributions through patents like FGF-CX and NOVX13 underscore his significant impact on the field, paving the way for transformative advancements in healthcare. Padigaru's journey exemplifies the power of creativity and collaboration in shaping a brighter future for medical science.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]